Literature DB >> 8679604

Folding nuclei of the scFv fragment of an antibody.

C Freund1, A Honegger, P Hunziker, T A Holak, A Plückthun.   

Abstract

The folding kinetics of the variable domains of the phosphorylcholine-binding antibody McPC603, combined into a scFv fragment [VH-(Gly4Ser)3-VL], were investigated by the use of fluorescence spectroscopy, nuclear magnetic resonance (NMR), and mass spectrometry (MS). All three methods gave evidence for the occurrence of a major kinetic intermediate during the refolding of the denatured, oxidized scFv fragment. This intermediate is formed within the first 30 s of folding and comprises exchange-protected amide protons of hydrophobic and aromatic amino acids, most of which are localized within the inner beta-sheet of the V(L) domain. In the subsequent slow step, most of the amide protons become protected with rate constants that are very similar for residues of both domains. These data are in agreement with the MS results, which indicate a cooperative folding event from the intermediate to the native state of the scFv fragment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679604     DOI: 10.1021/bi952764a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  The hydrogen exchange core and protein folding.

Authors:  R Li; C Woodward
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.

Authors:  M Jäger; A Plückthun
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

3.  A top-down approach to mechanistic biological modeling: application to the single-chain antibody folding pathway.

Authors:  Scott Hildebrandt; David Raden; Linda Petzold; Anne Skaja Robinson; Francis J Doyle
Journal:  Biophys J       Date:  2008-07-18       Impact factor: 4.033

4.  The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity.

Authors:  Matthias J Feige; Sandra Groscurth; Moritz Marcinowski; Zu Thur Yew; Vincent Truffault; Emanuele Paci; Horst Kessler; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

5.  Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.

Authors:  Luis M Blancas-Mejía; Emily B Martin; Angela Williams; Jonathan S Wall; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2017-09-01       Impact factor: 2.352

Review 6.  How antibodies fold.

Authors:  Matthias J Feige; Linda M Hendershot; Johannes Buchner
Journal:  Trends Biochem Sci       Date:  2009-12-21       Impact factor: 13.807

7.  Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.

Authors:  Luis M Blancas-Mejía; Alexander Tischer; James R Thompson; Jonathan Tai; Lin Wang; Matthew Auton; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2013-10-22       Impact factor: 5.469

8.  Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.

Authors:  P H Tan; B M Sandmaier; P S Stayton
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

9.  An unfolded CH1 domain controls the assembly and secretion of IgG antibodies.

Authors:  Matthias J Feige; Sandra Groscurth; Moritz Marcinowski; Yuichiro Shimizu; Horst Kessler; Linda M Hendershot; Johannes Buchner
Journal:  Mol Cell       Date:  2009-06-12       Impact factor: 17.970

10.  The Intrinsic Dynamics and Unfolding Process of an Antibody Fab Fragment Revealed by Elastic Network Model.

Authors:  Ji-Guo Su; Xiao Zhang; Xiao-Ming Han; Shu-Xin Zhao; Chun-Hua Li
Journal:  Int J Mol Sci       Date:  2015-12-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.